Pierre Fabre acquires immuno-oncology assets from Igenica
Pierre Fabre Group acquired certain immuno-oncology assets from Igenica Biotherapeutics Inc. Specific projects and financial details were not disclosed.
- Product Purchase
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.